Solid Biosciences Inc
NASDAQ:SLDB
| Market Cap (Intraday) | 143.88M |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $1.84 |
| 50-Day MA | $2.16 |
| 200-Day MA | $3.86 |
Solid Biosciences Inc Stock, NASDAQ:SLDB
141 Portland Street, 5th floor, Cambridge, Massachusetts 02139
Phone: +1.617.337.4680
Number of Employees: 70
Description
Solid Biosciences, Inc. engages in the development of treatments for patients with Duchenne muscular dystrophy (DMD). It develops gene therapies, disease modifying therapies, and assistive devices for the cure of DMD. The company was founded by Ilan Ganot, Andrey J. Zarur, Matthew Bennett Arnold, Annie Ganot, and Gilad David Hayeem in March 2013 and is headquartered in Cambridge, MA.